13-Employee SoCal Startup Bioniz Has A $400 Million Valuation Post author:Sam Post published:December 19, 2017 Post category:BioPharma Forbes recently interviewed Nazli Azimi, the CEO and co-founder of Bioniz Therapeutics. Source: BioSpace You Might Also Like Rejected Again: Ablynx Turns Down Novo Nordisk's Sweetened $3.1B Bid January 7, 2018 CTI BioPharma Reports First Quarter 2017 Financial Results May 3, 2017 FDA Grants Yisheng Biopharma's Clinical Treatment its Second Orphan Drug Designation February 25, 2018
FDA Grants Yisheng Biopharma's Clinical Treatment its Second Orphan Drug Designation February 25, 2018
